Comparing the Outcomes of Pediatric Liver Transplantation

Background. Liver transplantation is a life-saving treatment for end-stage pediatric liver fail-ure. We aimed to present the results of pediatric liver transplants performed in our center in the last 11 years (between 2012 and March 2022) in association with prognostic factors affecting survival. Methods. Demographic characteristics, etiologic reasons, previous operations (Kasai proce-dure), morbidity, mortality, survival, and bilio-vascular complication rates were determined, and outcomes were evaluated. In the postoperative period, the duration of mechanical ventilation and intensive care unit stay and surgical and other complications were evaluated. Graft and patient survival rates were determined, and univariate and multivariate factors affecting these rates were evaluated. Results. In the last 10 years, 229 pediatric liver transplantaion (Pe-LT)/1513 adult liver tarans-plantation (Ad-LT) (21.35%) were performed in our center. This ratio (Pe-LT/Ad-LT ratio) is 1741/15,886 (10.95%) for our country. A total of 229 liver transplants were performed in 214 pediatric patients. Retransplantation was performed in 15 patients (6.55%). Cadaveric liver trans-plantation was performed in 9 patients. Graft survival rates were 87%, 83%, 78%, 78%, 78%, and 78% at <30 days, 30 to 90 days, 91 to 364 days, 1 to 3 years, and >3 years, respectively. Patient survival rates for <30 days, 30 to 90 days, 91 to 364 days, 1 to 3 years, and >3 years were 91.5%, 85.7%, 82%, 81.5%, and 81.5%, respectively. Our 5-year survival rates in meta-bolic diseases and the acute fulminant failure group are 93.8% and 100%, respectively. Conclusions. The fact that the 1-and 5-year survival rates are the same shows that when patients overcome biliary vascular and infectious problems, their survival is prolonged.